Publication | Closed Access

Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents

Tumor BiologyOncologyMalignant DiseasePreclinical ActivityMedicineNsc 628503Conventional Antineoplastic AgentsAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyCancer Research